CAMAC Energy Inc. (NYSE CAK) today announced that the Company’s Chairman and CEO, Dr. Kase Lawal, has adopted a prearranged trading plan in accordance with guidelines specified by Rule 10b5-1. Dr. Lawal will purchase up to 2 million shares of the Company’s common stock from time to time on the open market starting from November […]
Tranzyme, Inc. (TZYM) announced today that its drug candidate, TZP-102, did not meet its primary efficacy endpoint. Tranzyme’s Phase IIb study was for two doses of TZP-102 taken once daily against a placebo. Even all patients saw a reduction in gastroparesis symptoms after 12 weeks of treatment, the difference between TZP-102 and placebo was minimum […]
MRI Interventions (MRIC), a company with a revolutionary ClearPoint system that enables neurosurgeons to see inside the brain in real-time using direct MRI guidance while performing minimally invasive surgical procedures, today released strong 2012 third quarter (Q3) financial results. To-date, MRI Interventions has successfully implemented its ClearPoint system in 18 sites with the first case […]
Guided Therapeutics, Inc. (GTHP) today announced that it has submitted to FDA its PMA (premarket approval amendment) for the LuViva Advanced Cervical Scan (a non-invasive device used to detect cervical disease that leads to cancer). LuViva has been under FDA PMA review since September 23, 2010. FDA declined LuViva in January 20, 2012. In July, […]
MRI Interventions (MRIC) had BIG news on Monday. The stock saw strong trading and closed up 17%, paving the way for more gains this week. MRIC said they hired a new Head of Global Sales, a guy who was Director of Sales for Medtronic! Medtronic (NYSE: MDT), for those of you who are unaware, is […]
Tekmira Pharmaceuticals Corporation (TKMR) announced today that it has entered into a settlement agreement with Alnylam Pharmaceuticals, Inc. that resolves all litigation between the companies. Tekmira will receive $65 million within 10 days and is eligible to receive $10 million in near-term milestone payments expected to be received in 2013 as a result of the […]
Shelron Group , Inc. (SRNG) today announced that Dr. Alexandre Agaian, President and Chairman of Terra Energy and Resource Technologies, Inc. (“Terra”), has agreed to join the advisory board of The Shelron Group. Dr. Agaian’s bio: Dr. Agaian is a published scientific researcher, serial entrepreneur, and accomplished company builder. Since 2003, he has concentrated his […]
by BioTechIll Guest Author BIOLASE, Inc. (BIOL) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and Conformité Européene (CE) Mark approval for its EPIC 10™ diode soft tissue laser. EPIC EPIC™ offers the most precise control of tissue cutting for different procedures and tissue biotypes. With our […]
by BiotechIll Guest Author Cell Therapeutics, Inc. (CTIC) today announced that its paclitaxel poliglumex drug OPAXIO has been granted orphan-drug designation by the U. S Food and Drug Administration for the treatment of malignant brain cancer (glioblastoma multiforme). CTIC stock closed up 11.2% on the 4fold of its 10day average volume. Phase 2 study has […]
Peregrine Pharmaceuticals (PPHM ) announced today that it discovered major discrepancies between some patient sample test results and patient treatment code assignments during the course of preparing for an end-of-phase II meeting with regulatory authorities. Peregrine contracted with independent third-party contractors to execute treatment group assignments and oversee clinical trial material coding and distribution according […]
